TT
The startup specializes in small molecule therapeutics that enhance transmembrane protein drug discovery through advanced protein purification, structural determination, and mechanistic assays. By providing targeted transporter and ion channel programs, the company enables hospitals to effectively treat neurological and rare diseases using insights into protein structure and small molecule-protein interactions.
Cambridge, United Kingdom
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in small molecule therapeutics that enhance transmembrane protein drug discovery through advanced protein purification, structural determination, and mechanistic assays. By providing targeted transporter and ion channel programs, the company enables hospitals to effectively treat neurological and rare diseases using insights into protein structure and small molecule-protein interactions.